Xylazine - Medical and Public Health Imperatives

Affiliations

¹ From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia (M.A.A.).

Rahul Gupta et al. N Engl J Med. 2023.

. 2023 Jun 15;388(24):2209-2212.

doi: 10.1056/NEJMp2303120. Epub 2023 Apr 26.

¹ From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia (M.A.A.).

No abstract available

Comment in

Medical and Public Health Imperatives of Xylazine.
Levine M, Manini AF, Love J. Levine M, et al. N Engl J Med. 2023 Aug 24;389(8):770. doi: 10.1056/NEJMc2308155. N Engl J Med. 2023. PMID: 37611132 No abstract available.
Medical and Public Health Imperatives of Xylazine.
Cole RJ, Schaffer DH, Charlton NP. Cole RJ, et al. N Engl J Med. 2023 Aug 24;389(8):770-771. doi: 10.1056/NEJMc2308155. N Engl J Med. 2023. PMID: 37611133 No abstract available.
Medical and Public Health Imperatives of Xylazine.
López-Briz E, Olcina-Rodríguez JF. López-Briz E, et al. N Engl J Med. 2023 Aug 24;389(8):771. doi: 10.1056/NEJMc2308155. N Engl J Med. 2023. PMID: 37611134 No abstract available.
Medical and Public Health Imperatives of Xylazine. Reply.
Gupta R, Holtgrave DR, Ashburn MA. Gupta R, et al. N Engl J Med. 2023 Aug 24;389(8):771-772. doi: 10.1056/NEJMc2308155. N Engl J Med. 2023. PMID: 37611135 No abstract available.